Literature DB >> 15788473

Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies.

Joost F M Lensen1, Angelique L W M M Rops, Tessa J M Wijnhoven, Theo Hafmans, Wouter F J Feitz, Egbert Oosterwijk, Bernhard Banas, René J M Bindels, Lambert P W J van den Heuvel, Johan van der Vlag, Jo H M Berden, Toin H van Kuppevelt.   

Abstract

Glycosaminoglycans (GAG) play an important role in renal homeostasis. They are strongly negatively charged polysaccharides that bind and modulate a myriad of proteins, including growth factors, cytokines, and enzymes. With the aid of specific phage display-derived antibodies, the distribution of heparan sulfate (HS) and chondroitin sulfate (CS) domains in the normal human kidney was studied. HS domains were specifically located in basement membranes and/or surfaces of renal cells and displayed a characteristic distribution over the nephron. A characteristic location in specific parts of the tubular system was also observed. CS showed mainly an interstitial location. Immunoelectron microscopy indicated specific ultrastructural location of domains. Only partial overlap with any of seven different proteoglycan core proteins was observed. Two HS domains, one highly sulfated (defined by antibody HS4C3) and one low sulfated (defined by antibody RB4Ea12), were studied for their cell biologic relevance with respect to the proliferative effect of FGF-2 on human mesangial cells in vitro. Fibroblast growth factor 2 (FGF-2) binding was HS dependent. Addition of purified HS4C3 antibody but not of the RB4Ea12 antibody counteracted the binding and the proliferative effect of FGF-2, indicating that the HS4C3 domain is involved in FGF-2 handling by mesangial cells. In conclusion, specific GAG domains are differentially distributed in the normal human kidney and are likely involved in binding of effector molecules such as FGF-2. The availability of tools to identify and study relevant GAG structures allows the development of glycomimetica to halt, for instance, mesangial proliferation and matrix production as seen in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788473     DOI: 10.1681/ASN.2004050413

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

2.  Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation.

Authors:  Minh Bao Huynh; Christophe Morin; Gilles Carpentier; Stephanie Garcia-Filipe; Sofia Talhas-Perret; Véronique Barbier-Chassefière; Toin H van Kuppevelt; Isabelle Martelly; Patricia Albanese; Dulce Papy-Garcia
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 4.  Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.

Authors:  Tiziana Adage; Anna-Maria Piccinini; Angelika Falsone; Martin Trinker; James Robinson; Bernd Gesslbauer; Andreas J Kungl
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

6.  Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis.

Authors:  Abd A Alhasan; Julia Spielhofer; Marion Kusche-Gullberg; John A Kirby; Simi Ali
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

7.  Leptospira interrogans binds to human cell surface receptors including proteoglycans.

Authors:  Deborah D Breiner; Mark Fahey; Ryan Salvador; Jana Novakova; Jenifer Coburn
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

8.  Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.

Authors:  T J M Wijnhoven; M J W van den Hoven; H Ding; T H van Kuppevelt; J van der Vlag; J H M Berden; R A Prinz; E J Lewis; M Schwartz; X Xu
Journal:  Diabetologia       Date:  2007-12-06       Impact factor: 10.122

9.  Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.

Authors:  Emily F McNaughton; Andrew D Eustace; Sophie King; Richard B Sessions; Alasdair Kay; Michele Farris; Robert Broadbridge; Oksana Kehoe; Andreas J Kungl; Jim Middleton
Journal:  J Immunol       Date:  2018-03-23       Impact factor: 5.422

10.  Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.

Authors:  Douglas M McCarty; Julianne DiRosario; Kadra Gulaid; Smruti Killedar; Arie Oosterhof; Toin H van Kuppevelt; Paul T Martin; Haiyan Fu
Journal:  Metab Brain Dis       Date:  2011-01-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.